Deciphering protein-DNA interactions of KISS1 with transcription factors through molecular docking, molecular

Hetvi Shah1, Pranav Pillai2, Lipi Buch2

  • 1TREE Lab, Department of Biomedical and Life Sciences, School of Science, Navrachana University, Vadodara, India.

Insights

Kisspeptin-1 (KISS1) modulates key transcription factors to suppress metastasis in triple-negative breast cancer (TNBC). This study reveals KISS1

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Structural Biology

Background:

  • Metastasis is a critical challenge in triple-negative breast cancer (TNBC), lacking targeted therapies.
  • Kisspeptin-1 (KISS1) is a known metastasis suppressor with therapeutic potential.
  • Understanding KISS1's interaction with transcription factors (TFs) is crucial for TNBC treatment.

Purpose of the Study:

  • Investigate structural and regulatory interactions between KISS1 and metastasis-associated TFs.
  • Determine the binding affinity and stability of KISS1-TF complexes.
  • Validate the effect of KISS1 on TF expression in TNBC cells.

Main Methods:

  • TF identification using TFLink and molecular modeling with SWISS-MODEL.
  • Protein-DNA docking simulations using HADDOCK to assess binding.
  • Molecular dynamics simulations (150 ns) to analyze complex stability.
  • Experimental validation in MDA-MB-231 cells treated with Kisspeptin-10.

Main Results:

  • CDX2 exhibited the strongest binding to KISS1-DNA, followed by HDAC2, GATA2, NMYC, SP1, and FLI1.
  • Molecular dynamics simulations confirmed stable complexes for SP1, NMYC, and CDX2.
  • Kisspeptin-10 treatment upregulated SP1, NMYC, CDX2, GATA2, and downregulated FLI1 and HDAC2 in TNBC cells.
  • KISS1 selectively modulates TF activity towards anti-metastatic signaling.

Conclusions:

  • KISS1 acts as a selective transcriptional regulator in TNBC metastasis.
  • The findings highlight KISS1's potential as a therapeutic agent against TNBC metastasis.
  • Further research into KISS1-mediated transcriptional regulation could yield novel anti-cancer strategies.

Related Concept Videos

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.5K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.5K